VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

VJVirtual | Impact of COVID-19 on scientific research and treating patients

Geoffrey Oxnard • 9 Apr 2020
General

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, highlights the impact of COVID-19 on research studies and treating patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Geoffrey Oxnard

1:49
The Pitfalls of cell-free DNA sequencing
Geoffrey Oxnard • 28 Sep 2019
3:19
Cancer detecting and locating: cell-free DNA
Geoffrey Oxnard • 28 Sep 2019
4:50
TATTON: Phase 1b trial of AZD9291 for EGFR-mutant lung cancer
Geoffrey Oxnard • 30 May 2015
4:55
Cell-free DNA liquid biopsy in lung cancer
Geoffrey Oxnard • 9 Apr 2020

Related Videos

2:49
Pharmacovigilance and the purpose of clinical trials
Diana Lüftner
2:00
The NCRI: supporting and expediting UK cancer research
Richard Stephens
1:05
Critical data points in the production of biosimilars
Richard Markus
2:31
IO-chemo and IO-radio options for cancer treatment
John Bell
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals